Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹234 Cr
Revenue (TTM)
₹143 Cr
Net Profit (TTM)
₹11 Cr
ROE
0.4 %
ROCE
1.3 %
P/E Ratio
22
P/B Ratio
1.3
Industry P/E
37.29
EV/EBITDA
14.5
Div. Yield
0 %
Debt to Equity
0
Book Value
₹196.3
EPS
₹10.8
Face value
10
Shares outstanding
9,541,920
CFO
₹16.78 Cr
EBITDA
₹107.13 Cr
Net Profit
₹97.87 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Nureca
| -20.4 | -14.9 | -13.0 | 10.3 | -8.6 | -15.8 | -- |
|
BSE Healthcare
| -3.4 | -3.2 | -3.5 | 3.6 | 24.9 | 15.6 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Nureca
| 8.3 | -33.0 | -14.1 | -75.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Nureca
|
245.1 | 234.2 | 143.3 | 10.6 | 3.5 | 5.4 | 22 | 1.3 |
| 253.0 | 138.7 | 34.5 | -3.4 | -5.4 | -48.6 | -- | 10.1 | |
| 56.7 | 49.1 | 38.4 | 3.3 | -- | 19.6 | 14.7 | 2.0 | |
| 229.5 | 429.1 | 135.7 | 16.1 | -- | 36.8 | 26.6 | 6.7 | |
| 120.0 | 165.1 | 43.1 | 6.6 | -- | 40.6 | 24.9 | 2.6 | |
| 137.0 | 76.3 | 35.4 | 5.8 | 15.4 | 17 | 13.2 | 1.9 | |
| 1,253.7 | 12,739.9 | 1,781.6 | 341.3 | 19.8 | 12.4 | 36.6 | 4.3 | |
| 73.5 | 96.6 | 79.3 | 8.6 | 13.0 | 30.6 | 11.3 | 3.1 | |
| 190.0 | 318.2 | 92.4 | 4.7 | -- | 4.9 | 67.6 | 3.2 | |
| 201.5 | 7.8 | 0.1 | 0.0 | -- | 2 | 865.8 | 17.3 |
Nureca IPO: Information Analysis
6 min read•By Danish Khanna
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products;... orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, personal scales, yoga and exercise products, fitness tracking products, and dental and personal care products. It also provides mother and baby care products comprising baby feeding products, carry cots, baby skincare products, and bottle warmers and steamers; nutritional supplements and weight management products; and ECG products, fitness trackers, and smart weighing scales. In addition, the company provides orthopedic cushions, heating pads, and breast pumps. The company offers its products under the Dr Trust, Dr Physio, and Trumom brands. It markets its products through e-commerce platforms, distributors, retailers, and its websites. Nureca Limited was incorporated in 2016 and is based in Chandigarh, India. Read more
Incorporated
2016
Chairman
Saurabh Goyal
Managing Director
Saurabh Goyal
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Nureca Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Nureca Ltd is ₹245.10 (NSE) and ₹246.00 (BSE) as of 19-Mar-2026 12:59 IST. Nureca Ltd has given a return of -8.57% in the last 3 years.
The P/E ratio of Nureca Ltd is 22.00 times as on 19-Mar-2026, a 41 discount to its peers’ median range of 37.29 times.
The P/B ratio of Nureca Ltd is 1.25 times as on 19-Mar-2026, a 71 discount to its peers’ median range of 4.34 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
248.64
|
1.08
|
|
2024
|
0.00
|
1.32
|
|
2023
|
0.00
|
1.54
|
|
2022
|
30.30
|
6.70
|
|
2021
|
12.98
|
3.69
|
The 52-week high and low of Nureca Ltd are Rs 343.00 and Rs 203.62 as of 19-Mar-2026.
Nureca Ltd has a market capitalisation of ₹ 234 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Nureca Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-3.30
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.